chlorpheniramine maleate; pseudoephedrine hydrochloride
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE (chlorpheniramine maleate; pseudoephedrine hydrochloride) by Ascentage Pharma. Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose and 1 more indications. First approved in 1985.
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
A combination oral decongestant and antihistamine indicated for relief of upper respiratory allergy symptoms including runny nose, itchy and watery eyes, sneezing, and throat itching due to hay fever and other allergies. Chlorpheniramine maleate blocks histamine receptors to reduce allergic response, while pseudoephedrine acts on α-sympathetic receptors to produce vasoconstriction and nasal decongestion. Delivered as an extended-release capsule for sustained symptom relief.
Product faces imminent loss of exclusivity with moderate competitive pressure (30/100), indicating cost-control and transition planning will dominate brand strategy.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE at Ascentage Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on this product offers limited career growth due to LOE approaching and minimal clinical development. Roles focus on maximizing remaining brand value, managing decline, and transitioning to generic/OTC channels—experience in commercial optimization and market access critical.